Abstract
Human neuroblastoma cells often carry nonrandom chromosomal abnormalities signaling genetic alterations. Quite frequent are “double minutes” (DMs) and homogeneously staining regions (HSRs), both cytogenetic manifestations of amplified DNA, and chromosome 1 p deletions indicating loss of genetic information. With the identification of amplified N-myc and the demonstration of a consensus deletion spanning the chromosome 1 p36.1–2 region it now appears likely that both amplification of a cellular oncogene and loss of a tumor suppressor gene play important roles in neuroblastoma (Fig.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schwab M, Amler LC (1990) Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes Cancer 1:181–193
Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J (1983) Amplified DNA with limited homology of myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 305:245–248
Berthold F (1990) Biology of neuroblastoma. In: Pochedly C (ed) Neuroblastoma: tumor biology and therapy. CRC Press, Boca Raton Ann Arbor Bosten, pp 1–27
Schwab M, Varmus HE, Bishop JM (1985) The human N-myc gene contributes to tumorigenic conversion of mammalian cells in culture. Nature 316:160–162
Small M, Hay N, Schwab M, Bishop JM (1987) Neoplastic transformation by the human gene N-myc. Mol Cell Biol 7:1638–1645
Schweigerer L, Breit S, Wenzel A, Tsunamoto K, Ludwig R, Schwab M (1990) Augmented MYCN expression advances the malignant phenotype and induces autocrine growth factor activity in human neuroblastoma cells. Cancer Res 50:4411–4416
Schwab M, Bishop JM (1988) Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence. Proc Natl Acad Sci USA 85:9585–9589
Van Lohuizen M, Breuer M, Berns A (1989) N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas. EMBO J 8:133–136
Dildrop R, Ma A, Zimmermann K, Hsu E, Tesfaye A, de Pinho R, Alt F (1989) IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. EMBO J 8:1121–1128
Rosenbaum H, Webb E, Adams JM, Cory S, Harris AW (1989) N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J 8:749–755
Ibson JM, Rabbits PH (1988) Sequence of a germ-line N-myc gene and amplification as a mechanism of activation. Oncogene 2:399–402
Kanda N, Schreck R, Alt F, Bruns G, Baltimore D, Latt S (1983) Isolation of amplified DNA sequences from IMR-32 human neuroblastoma cells: facilitation by fluorescence-activated flow-sorting of metaphase chromosomes. Proc Natl Acad Sci USA 80:4069–4073
Shiloh Y, Shipley J, Brodeur GM, Bruns G, Korf B, Donlon T, Schreck RR, Seeger T, Sakai K, Latt SA (1985) Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines. Proc Natl Acad Sci USA 82:3761–3765
Shiloh Y, Korf B, Kohl NE, Sakai K, Brodeur GM, Harris P, Kanda N, Seeger RC, Alt FW, Latt SA (1986) Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas. Cancer Res 46:5297–5301
Zehnbauer BA, Small D, Brodeur GM, Seeger R, Vogelstein B (1988) Characterization of NMYC amplification units in human neuroblastoma cells. Mol Cell Biol 8:522–530
Tonin PN, Yeger H, Stallings RL, Srinavasan PR, Lewis WH (1989) Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyuera-resistant hamster cell lines. Oncogene 4:1117–1121
Roninson I (1983) Detection and mapping of homologous, repeated and amplified DNA sequences by DNA renaturation in agarose gels. Nucleic Acids Res 11:5413–5431
Kinzler KW, Zehnbauer BA, Brodeur GM, Seeger RC, Trent J, Meltzer PS, Vogelstein B (1986) Amplification units containing human MYCN and MYC genes. Proc Natl Acad Sci USA 83:1031–1035
Amler LC, Schwab M (1989) Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. Mol Cell Biol 9:4903–4913
Schwab M, Varmus HE, Bishop JM, Grzeschik KH, Sakaguchi A, Brodeur G, Trent J (1984) Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 308:288–291
Stark GR, Debatisse M, Giulotto E, Wahl GM (1989) Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57:901–908
Bartram CR, Berthold F (1987) Amplification and expression of the N-myc gene in neuroblastoma. Eur J Pediatr 146:162–165
Brodeur G, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121–1124
Nakagawara A, Ikeda K, Tsuda T, Hig-ashi K (1988) Biological characteristics of NMYC amplified neuroblastoma in patients over one year of age. In: Evans A, d’Angio G, Knudson A, Seeger RC (eds) Advances in neuroblastoma research. Liss, New York, pp 31–39
Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel WE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111–1116
Carlsen NLT, Christensen IJ, Schroeder H, Bro PV, Hesselberg K, Jensen KB, Nielsen OH (1986) Prognostic value of different staging systems in neuroblastomas and completeness of tumour excision. Archives Disease Childhood 61:832–842
Cohn SL, Herst CV, Maurer HS, Rosen ST (1987) N-myc amplification in an infant with stage IV-s neuroblastoma. J Clin Oncol 5:1441–1444
Tonini GP, Verdona G, de Bernardi B, Sansone R, Massimo L, Cornaglia-Ferraris P (1987) N-myc oncogene amplification in a patient with IV-s neuroblastoma. Am J Pediat Hematol Oncol 9:8–10
Biedler JL, Helson L, Spengler BS (1973) Morphology and growth, tumorigenecity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643–2652
Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL, Tsiatis AA (1981) Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41:4678–4686
Hansen MF, Cavanee WK (1987) Genetics of cancer predisposition. Cancer Res 47:5518–5527
Martinsson T, Weith A, Cziepluch C, Schwab M (1986) Chromosome 1 deletions in human neuroblastomas: generation and fine mapping of microclones from the distal 1 p region. Genes Chromosomes Cancer 1:67–78
Weith A, Martinsson T, Cziepluch C, Brüderlein S, Amler LC, Berthold F, Schwab M (1989) Neuroblastoma consensus deletion maps to chromosome lp36.1–2. Genes Chromosomes Cancer 1:159–166
Fong CT, Dracopoli NC, White P, Merrill PT, Griffith RC, Housman DE, Brodeur GM (1989) Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: Correlation with N-myc amplification. Proc Natl Acad Sci USA 86:3753–3757
Vogel F, Motulsky AG (1986) Human genetics, 2nd edn. Springer, Berlin Heidelberg New York
Bird A (1987) CpG islands as gene markers in the vertebrate nucleus. Trends Genet 3:342–347
Suzuki T, Yokota J, Mugishima H, Okabe I, Sugimura T, Terada M (1989) Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 49:1095–1098
Schwab M (1985) Amplification of N-myc in human neuroblastomas. Trends Genet 1:271–275
Schwab M (1986) Amplification of proto-oncogenes and tumor progression. In Kahn P, Graf T (eds) Oncogenes and growth control. Springer, Berlin Heidelberg New York, pp 332–339
Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schwab, M. (1992). Human Neuroblastoma: Paradigm for a Tumor with Oncogene Amplification and Loss of a Putative Tumor Suppressor Gene. In: Neth, R., Frolova, E., Gallo, R.C., Greaves, M.F., Afanasiev, B.V., Elstner, E. (eds) Modern Trends in Human Leukemia IX. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 35. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76829-3_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-76829-3_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-54360-2
Online ISBN: 978-3-642-76829-3
eBook Packages: Springer Book Archive